Working Papers

To request copy of a specific working paper, contact cbi@mit.edu

Douglas, Frank and Gigi Hirsch. Global Outsourcing: Defining China’s Leading Edge, 2006. (PDF 70KB)

Stallings, Sarah C., Stan N. Finkelstein, Anthony J. Sinskey, et al. An Economic Framework for Evaluating Personalized Medicine, MIT Program on the Pharmaceutical Industry. (POPI) Working Paper No. 64-03, revised May 2005.

Finkelstein, Stan N., Niraj L. Sehgal and Randall S. Stafford. National Trends in Treatment for Diabetes Mellitus, MIT Program on the Pharmaceutical Industry. (POPI) Working Paper No. 66-04, 2004.

Raju, G.K. and Charles L. Cooney. Active Learning from Process Data, MIT Program on the Pharmaceutical Industry (POPI) Working Paper No. 60-01, June 2001.

Stallings, Sarah C., Robert H. Rubin, Thomas J. Allen, et al. The Contributions of Science and Technology in Advancing Society’s Needs through Drug Development, MIT Program on the Pharmaceutical Industry (POPI) Working Paper No. 58-01, February 2001.

Allen, Thomas J., Ralph Katz, Frank Basa and Stephen White. Project Management and the Performance of Drug Development Teams, MIT Program on the Pharmaceutical Industry (POPI) Working Paper No. 48-99, 1999.

Myers, Stewart C. and Christopher D. Howe. Life-Cycle Financial Model of Pharmaceutical R&D, MIT Program on the Pharmaceutical Industry (POPI) Working Paper No. 41-97, April 1997.

Basa, Frank and Thomas J. Allen. Project Management and the Locus of Decision-Making in Drug Development, MIT Program on the Pharmaceutical Industry (POPI) Working Paper No. 30-96, February 1996.

Raju, G.K. and Charles L. Cooney. ‘Benchmarking’ Pharmaceutical Manufacturing Performance, MIT Program on the Pharmaceutical Industry (POPI) Working Paper No. 37-96, 1996.

Allen, Thomas J. and Frank Basa. Managing the Drug Development Process: A Preliminary Report on a Study of Project Management in the Pharmaceutical Industry, January 1994.